and K3940A were made in two potential ATPbinding motifs (amino acids 2370-2375 and 3937-3940) In the presence of 1 mM AMP-PCP, Ca# + -activation curves were shifted to higher affinity and maximal binding was increased to a similar extent for wild-type RyR1 and mutants. ATP sensitivity of channel opening was also similar for wild-type
INTRODUCTION
Ca# + -release channels of sarcoplasmic reticulum (ryanodine receptors, or RyRs) are large homotetrameric molecules with molecular masses of $ 2.26 MDa [1] [2] [3] [4] . These channels are modulated by endogenous and exogenous ligands such as Ca# + , ATP, caffeine, calmodulin, Mg# + , Ruthenium Red and ryanodine, but the extent of modulation varies among RyR1, the isoform expressed in skeletal muscle, RyR2, expressed in cardiac muscle, and RyR3, expressed more ubiquitously [5] [6] [7] . Ca# + is a basic modulator of Ca# + -release channel function. At low concentrations, Ca# + activates both skeletal-and cardiac-muscle Ca# + -release channels ; at high concentrations, it inactivates the skeletal-muscle Ca# + -release channel. Ca# + activation and inactivation sites are localized in the C-terminal one-fifth of the RyR1 molecule region [8] [9] [10] [11] [12] . This C-terminal region of RyR also forms the Ca# + -conducting pore and contains both high-and low-affinity binding sites for ryanodine [8, [13] [14] [15] . The molecular mechanisms underlying the interactions of modulators with RyRs are poorly understood.
Adenine nucleotides activate Ca# + -release channels with EC &! values in the millimolar range. Activation is probably through a molecular site different from, but interacting with, the Ca# + -activation or Mg# + -binding site [5] [6] [7] . Motifs identifying potential 3503-3506 and 3937-3940, conform to the consensus ATPbinding sites in GroES. Ogawa [22] has proposed that this motif might form a potential binding site for ATP in RyR proteins, since neither the ATP bound to this site in GroES nor the ATP which activates the Ca# + -release channel is hydrolysed.
Caffeine has long been used as a tool for studying excitationcontraction coupling and the function of Ca# + -release channels [23] . It activates the Ca# + -release channel at concentrations below 2 mM by increasing Ca# + sensitivity [5] [6] [7] 24] , but, at concentrations above 5 mM, the action of caffeine on the channel is more direct. Caffeine is also used in the clinical diagnosis for malignant hyperthermia (MH) in skeletal muscle [25] . RyR2 is more sensitive to caffeine activation than RyR1 [7, [26] [27] [28] , but the binding site for caffeine in these two molecules has not been defined. This functional difference might be due to differences in binding sites for caffeine, or to differences in other structures which determine caffeine sensitivity. For example, deletion of amino acids 4272-4535 in RyR1 increases the sensitivity of the mutant RyR1 channel to caffeine and Ca# + [29] . Thus the deleted region might form an inhibitory domain for Ca# + and\or caffeine activation of RyR1. Expression of the C-terminal one-fifth of the RyR1 sequence was sufficient to form a functional Ca# + -release channel, but the channel was not caffeine-activated, demonstrating that upstream sequences are required for regulation of the Ca# + -release channel by caffeine [30] .
Mutations causing MH and central core disease (CCD) are clustered in three regions lying between amino acids 35 and 614 (MH domain 1), 2163 and 2458 (MH domain 2) and 4800 and 4900 (MH domain 3) [25, 31] . Mutations in MH domains 1 and 2 increase the sensitivity of the channel to caffeine and halothane [32] [33] [34] [35] , suggesting that both domains are involved in caffeine activation and thus contain potential caffeine-binding site(s). A CCD mutation found in MH region 3, however, had normal caffeine and halothane sensitivity when expressed as a heterozygote [31] .
In an attempt to identify potential ATP-binding sites in the Ca# + -release channel, we have carried out alanine-scanning mutagenesis of amino acids in two motifs : amino acids 2370-2375, located in MH domain 2, and 3937-3940, by creating the mutants G2370A, G2372A, G2373A, G2375A, Y3937A, S3938A, G3939A and K3940A. Since [$H]ryanodine only binds to open channels, high-affinity [$H]ryanodine binding to the mutants was used as a means of detecting channel activation by adenosine 5h-[β,γ-methylene]triphosphate (AMP-PCP), Ca# + and caffeine. We also used Ca# + photometry to measure Ca# + release induced by caffeine and 4-chloro-m-cresol (a skeletal-muscle Ca# + -release channel agonist) in HEK-293 cells expressing wild-type and mutant RyR1. Mutations of any these residues had no effect on ATP activation of RyR1, but mutations G2370A, G2373A and G2375A in MH domain 2 lowered sensitivity to caffeine and 4-chloro-m-cresol activation.
MATERIALS AND METHODS

Materials
Plasmid bluescript KS(j), restriction endonucleases and other DNA-modifying enzymes were from Stratagene, Boehringer Mannheim, New England Biolabs, Promega and Amersham Pharmacia Biotech ; fura 2 acetoxymethyl ester was from Molecular Probes ; caffeine, AMP-PCP and protease inhibitors were from Sigma ; [$H]ryanodine was from DuPont NEN ; unlabelled ryanodine and CHAPS were from Calbiochem ; phosphatidylcholine was from Northern Lipids. Monoclonal antibody 34C was a kind gift from Dr Judith Airey (University of Nevada School of Medicine, Reno, NV, U.S.A.) [36] . All other reagents were of reagent grade or the highest grade available.
Oligonucleotide-directed mutagenesis
Site-directed mutagenesis of RyR1 cDNA was carried out in cassettes which were excised from the full-length sequence in pBluescript KS(j) (pBS-RyR1) using unique restriction endonucleases engineered into the molecule [34] . In this study, mutagenesis involved cassettes C6 (SpeI-Spl I) and C9 (NdeI-NheI) in vector pBS2 [34] . Site-specific mutagenesis was performed according to the method of Kunkel [37] . The complete sequence of the mutated fragment was confirmed by DNA sequencing. Fragments with the desired mutations were subcloned back into their original positions in pBS-RyR1, and then the entire sequence was excised with XbaI and HindIII (bluntended) and subcloned into XbaI and SmaI sites in modified pMT2 vector, in which additional multiple cloning sites were created (EcoRI-XbaI-NotI-SmaI-KpnI-Sal I-EcoRI) for expression in HEK-293 cells.
Cell culture and DNA transfection
Culture of HEK-293 cells and cDNA transfection by the calcium phosphate precipitation method [38] were carried out as described previously [39] .
Fluorescence measurements
A microfluorimetry system (Photon Technology International) was used to monitor the fura 2 acetoxymethyl ester fluorescence changes in transiently transfected or non-transfected HEK-293 cells, as described previously [28] . 6 .0q. To test caffeine sensitivity in the mutants, caffeine concentrations, ranging from 0 to 100 mM, were added to the binding buffer ( pCa 6.7). The incubation time was 1 h for all. Free Ca# + was calculated using the apparent binding constants described by Fabiato [40] . 
SDS/PAGE, immunoblotting and protein assay
RESULTS
Mutagenesis and expression of mutant RyR1 cDNAs
Amino acids 1081-1084, 2370-2375 and 3937-3940 are conserved within the RyR family. The alignments for the last two motifs in the RyR family are shown in Figure 1 (A). Mutants G2370A, G2372A, G2373A, G2375A, Y3937A, S3938A, G3939A and K3940A were constructed and expressed in HEK-293 cells.
Western blots of whole-cell lysates with monoclonal antibody 34C are presented in Figure 1 (B). No expression of RyR1 was observed in non-transfected or vector-transfected HEK-293 cells, but wild-type RyR and all of the mutant RyR1 cDNAs were expressed at readily detectable levels. There was also no significant difference in apparent molecular mass between wild-type and mutant RyR1 proteins. (Figures 3 and 4) . When 1 mM AMP-PCP was present, the Ca# + -activation curve was shifted to the left in wild-type RyR1 and in all of the mutants (Figures 3 and 4) . EC &! values in the presence of AMP-PCP were increased over those in the absence of AMP-PCP, and the magnitude of the change was similar for wild-type RyR1 and mutant RyR1 ( Figure 4 and Table 1 (Table 1 ). These data indicate that Ca# + activation and the effect of AMP-PCP on Ca# + activation were normal in these mutants. Slopes for Ca# + activation ranged between 0.9 and 1.6 (Table 1) . These values are lower than those observed in our previous experiments with recombinant RyR1, in which the slopes ranged from 1.5 to 2.1 [28] . Sample preparation was different in this study, in that we excluded soluble cellular components and much of the detergent CHAPS by sedimentation. binding in the absence of caffeine, but was increased as the concentration increased for both wild-type and the mutants.
AMP-PCP activation of high-affinity [ 3 H]ryanodine binding to mutants
Caffeine activation of high-affinity [ 3 H]ryanodine binding to mutants
[$H]Ryanodine binding reached a peak at 30 mM caffeine ( Figure  6 ) and declined at higher concentrations (results not shown), demonstrating the desensitizing effect of high concentrations of 
caffeine. EC
&! values were obtained by fitting curves between 0.3 and 30 mM caffeine, after normalization to the value at 30 mM. The data are summarized in Table 2 . Mutants G2370A, G2373A and G2375A, but not G2372A, Y3937A, S3938A, G3939A and K3940A, had higher EC &! values, indicating that mutants G2370A, G2373A and G2375A had decreased sensitivity to caffeine activation.
Ca 2 + photometric measurement of caffeine-induced Ca 2 + release in transfected HEK-293 cells
To confirm the diminished caffeine sensitivity of mutants G2370A, G2373A and G2375A, we used Ca# + photometry to measure the properties of caffeine-induced Ca# + release in HEK-293 cells transfected with wild-type and mutant RyR1 cDNAs Figure 7(B) shows that cells transfected with G2375A cDNA responded only to higher concentrations of caffeine, and similar traces were obtained for mutants G2370A, G2372A and G2373A.
Threshold values for caffeine activation of Ca# + release for wild-type and mutant RyR1 are summarized in Table 2 . Threshold values for the four mutants G2370A, G2372A, G2373A and G2375A ranged from 1.0 to 5.2 mM caffeine. Threshold values for RyR1 mutants Y3927A, S3938A, G3939A and K3940A ranged from 0.3 to 0.5 mM caffeine. These results indicate that the sensitivity to caffeine in the mutants between amino acids 2370 and 2375 is lower than in the wild type.
Measurement of EC &! values confirmed an alteration of caffeine ]ryanodine in a buffer containing caffeine concentrations ranging from 0 to 100 mM at pCa 6.0 in a total volume of 0.25 ml. The experiments were carried out as described in the Materials and methods section. , RyR1 ; $, G2370A ; >, G2372A ; X, G2373A ; 4, G2375A ; , Y3937A ; #, S3938A ; =, G3939A ; W, K3940A. Solid line, RyR1 ; dotted lines, mutants. EC 50 and slope values for each experiment were obtained by sigmoidal fitting and are summarized in Table 2 .
sensitivity in the 2370-2375 mutants. Peak amplitude for each caffeine application was normalized to the peak amplitude for maximal Ca# + release induced by 30 mM caffeine in each trace, and the resultant dose-response curves were obtained from three to four independent experiments, like those shown in Figures  7(A) and 7 
(B). EC
&! values for RyR1 and the mutants were calculated by fitting the caffeine dose-response curves with an equation for logistic dose-response. These values are listed in Table 2 . The EC &! values for G2370A, G2372A, G2373A and G2375A were significantly higher than the EC &! values for wildtype RyR1 or mutants Y3937A, S3938A, G3939A or K3940A, confirming the decreased sensitivity to caffeine activation of mutants G2370A, G2373A and G2375A. The slope for caffeine activation was about 2 (range of 1.6-2.9) for RyR1 and all mutants ( Table 2 ). The slope obtained for RyR1 and mutants G2370A, G2372A, G2373A and G2375A from this assay differed 
Figure 7 Fluorescence measurements of Ca 2 + release from internal stores into the cytoplasm of HEK-293 cells transfected with RyR1 and mutant cDNA, induced by incremental concentrations of caffeine
Representative Ca 2 + transients in HEK-293 cells transfected with RyR1 (A) and G2370A (B) cDNAs were induced by incremental concentrations of caffeine. Cells on a coverslip were treated as described previously [28] . Individual peak amplitudes of 340/380 nm ratio (fluorescence ratio at the highest response to caffeine minus the ratio at rest) for wild-type and mutant RyR1 were collected and normalized to the maximal amplitude of the peak response in fluorescence ratio (340/380 nm) induced by 30 mM caffeine. Dose-response curves, expressed as meanspS.E.M., for wild-type (solid line) and mutants (dashed lines) are shown in (C). EC 50 and slope values for each independent experiment are summarized in Table 2 . Symbols are as in Figure 6 . &! values for G2370A, G2373A and G2375A were significantly higher than that for wild-type RyR1, whereas values for other mutants G2372A, Y3937A, S3938A, G3939A and K3940A were similar to that for the wild-type, indicating the decreased sensitivity to 4-chloro-mcresol activation of mutants G2370A, G2373A and G2375A. The slope for 4-chloro-m-cresol activation was similar between RyR1 and all the mutants (inset to Figure 8 ).
DISCUSSION
ATP acts as a non-hydrolysed ligand for the activation of several receptors and channels located in cell-surface and intracellular membranes. Extracellular ATP activates P2X receptors (ligandgated cation channels) and a family of seven transmembrane Gprotein-coupled receptors (P2Y receptors) [44] . Intracellular ATP also activates ion channels such as ATP-sensitive K + channels [45] and ryanodine receptors [6, 7] . In contrast with the knowledge base for ATP-sensitive K + channels [45] , the structural and functional basis for ATP modulation of RyR and the physiological importance of ATP modulation are poorly understood. [46, 48] . Adenine nucleotides are most likely to bind to an interaction site to activate the channel rather than to participate in phosphorylation to modify channel function. Nevertheless, phosphorylation of RyR1 and RyR2 modulates channel function [5] [6] [7] .
The existence of binding sites for adenine nucleotides has been confirmed in native RyR1 through photoaffinity labelling of ATP analogues [4, 20, 55, 56] . The binding domains have been localized following proteolysis to several fragments, two of which were as small as 27 and 13 kDa [20, 55] . Unfortunately, amino acid sequencing was not carried out, so the more detailed location of the binding sites was not determined.
To carry out structure\function analysis of potential ATPbinding sites in RyR, we used site-directed mutagenesis, expression and functional analysis to test the effect of mutagenesis of specific amino acids on activation of the ryanodine receptor. Since there is no typical nucleotide-binding site in the primary sequence of RyR1, we carried out mutagenesis on two consensus sequences, GXGXXG and Y(G\A\S\T)(V\G) (K\T\Q\S\N), for potential ATP-binding sites. From a number of consensus sequences, we selected conserved amino acid sequences 2370-2375 and 3937-3940 for this study. We detected a 1. This mutant had increased sensitivity to activation by Ca# + , caffeine and 4-chloro-m-cresol. These data strongly suggest that MH and CCD mutations in MH region 2 alter the conformation of RyR1, leading to an increased affinity for caffeine and 4-chloro-m-cresol.
In the present study, mutants G2370A, G2373A, G2375A and probably G2372A in MH domain 2 were found to decrease caffeine sensitivity and threshold values in both [$H]ryanodinebinding and caffeine-induced Ca# + -release assays, the opposite to that observed with MH\CCD mutations. These results suggest that amino acids 2370-2375 are involved in caffeine activation, and may form part of the caffeine-binding site. They also imply that the caffeine-binding site is very complex, perhaps with different domains having distinct functions ; some inhibitory, others stimulatory. Since caffeine activates the Ca# + -release channel by sensitizing it to Ca# + activation, it is possible that amino acids 2370-2375 participate in association of the caffeinebinding site with the Ca# + -activation site. Mutations G2370A, G2373A and G2375A may impair this link, leading to a diminished response at low caffeine concentrations. It will be difficult, however, to define the caffeine interaction site in RyR, because of the low affinity of binding of caffeine to RyR proteins.
RyR1 carrying MH mutation G2434R had an increased sensitivity to activation, in a [$H]ryanodine-binding assay, by 4-chloro-m-cresol, a skeletal-muscle Ca# + -release channel agonist [33, 57] . 4-Chloro-m-cresol has been identified recently as a trigger of MH in susceptible swine [58, 59] and has been recommended for use in a supplementary test for diagnosis of MH [60, 61] . In the present study, mutants G2370A, G2373A and G2375A had decreased 4-chloro-m-cresol sensitivity of activation, in parallel with decreased caffeine sensitivity, suggesting that MH domain 2 is an important regulatory domain for both caffeine and 4-chlorom-cresol. Similar to the case of caffeine, interaction site(s) in RyR Ca# + -release channels for 4-chloro-m-cresol remain to be defined.
In conclusion, mutations in two predicted ATP-binding sites (amino acids 2370-2375 and 3937-3940) of RyR1 did not alter ATP activation of [$H]ryanodine binding to the RyR channel, most likely ruling out the possibility of these two regions being ATP-binding sites. However, mutations in amino acids 2370-2375, which are located in MH domain 2, resulted in decreased caffeine and 4-chloro-m-cresol sensitivity. Recently several mutations in the corresponding region of RyR2 have been associated with catecholaminergic polymorphic ventricular tachycardia and arrhythmogenic right ventricular cardiomyopathy type 2 [62, 63] . This, together with the fact that MH domain 2 is a hot spot for MH and CCD mutations, highlights the importance of this domain in channel function.
